Serodiagnosis of cutaneous leishmaniasis: Assessment of an enzyme- linked immunosorbent assay using a peptide sequence from gene B protein

American Journal of Tropical Medicine and Hygiene

Volumn 55, Issue 5, 1996, Pages 490-495

  Jensen, A T R ^a   Gaafar, A ^a   Ismail, A ^a   Christensen, C B V ^a   Kemp, M ^a   El Hassan, A M ^b   Kharazmi, A ^c   Theander, T G ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF KHARTOUM   (Sudan)

^c Mental Health Services CPH   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANTIBODY; ANTIGEN; GLYCOPROTEIN; LIGAND; PEPTIDE; STIBOGLUCONATE SODIUM; SYNTHETIC PEPTIDE;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PLASMA; PROMASTIGOTE; SERODIAGNOSIS; SKIN LEISHMANIASIS; SMEAR;

LEISHMANIA DONOVANI; LEISHMANIA MAJOR;

EID: 0029803188     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1996.55.490     Document Type: Article

References (26)

1. El-Safi SH, Peters W. El-Toam B, El-Kadarow A, Evans DA, 1991. Studies on leishmaniasis in the Sudan. 2. Clinical and parasitological studies on cutaneous leishmaniasis. Trans R Soc Trop Med Hyg 85: 457-464.
2. El-Safi SH. Peters W, 1991. Studies on leishmaniasis in the Sudan. I. Epidemic of cutaneous leishmaniasis in Khartoum. Trans R Soc Trop Med Hyg 85: 44-47.
3. Homeida MMA, Sadig M, Ghalib HIM. Gaafar A, Harron DWG, 1987. Cutaneous leishmaniasis epidemic in the Sudan. Int J Pharmacol I: 142-144.
4. Guirges Y, 1971. Natural and experimental re-infection of man with oriental sore. Ann Trop Med Parasitol 65: 197-205.
5. Bryceson ADM, 1976. Tropical dermatology: cutaneous leishmaniasis. Br J Dermatol 94: 223-226.
6. Kubba R, El Hassan AM, Al-Gindan Y, Omer AHS, Kutty MK, Saeed MBM, 1987. Dissemination in cutaneous leishmaniasis I. Subcutaneous nodules. Int J Dermatol 26: 300-304.
7. Elassad, AMS, Younis SA, Siddig M, Grayson J, Petersen E, Ghalib HW, 1994. The significance of blood levels of IgM, IgA, IgG and IgG subclasses in Sudanese visceral leishmaniasis patients. Clin Exp Immunol 95: 294-299.
8. Okongo-Odera EA, Kurtzhals JAL, Hey AS, Kharazmi A. 1993 Measurement of serum antibodies against native Leishmania gp63 distinguishes between ongoing and previous L. donovani infection. APMIS 101: 642-646
9. Hommel M, Peters W, Ranque J. Quilici M, Lanotte G, 1978. The micro-ELISA technique in the serodiagnosis of visceral leishmaniasis. Ann Trop Med Parasitol 72: 213-218.
10. El-Safi SH, Evans DA, 1989. A comparison of the direct agglutination test and enzyme-linked immunosorbent assay in the sero-diagnosis of leishmaniasis in the Sudan Trans R Soc Trop Med Hyg 83: 334-337.
11. Mengistu G, Akuffo H, Fehniger TE, Negese Y, Nilsen R, 1992. Comparison of parasitological and immunological methods in the diagnosis of leishmaniasis in Ethiopia. Trans R Soc Trop Med Hyg 86: 154-157
12. Roffi J, Dedet JP, Desjeux P, Garre MT, 1980. Detection of circulating antibodies in cutaneous leishmaniasis by enzyme-linked immunosorbent assay (ELISA). Am J Trop Med Hyg 29: 183-189.
13. Edrissian GH, Daracian P, 1979. A comparison of the enzymelinked immunosorbent assay and indirect fluorescent antibody test in the sero-diagnosis of cutaneous and visceral leishmaniasis in Iran Trans R Soc Trop Med Hyg 73: 289-292.
14. Flinn HM, Rangarajan D, Smith DF, 1994. Expression of a hydrophilic surface protein in infective stages of Leishmania major. Mol Biochem Parasitol 65: 259-270.
15. Pimenta PFP, Pinto da Silva P, Rangarajan D, Smith DF, Sacks DL, 1994. Leishmania major: association of the differentially expressed gene B protein and the surface lipophosphoglycan as revealed by membrane capping. Exp Parasitol 79: 468-479.
16. Kadaro AY, Ghalib HW, Ali MS, Eltoum I, Ismail A, Gaafar A, Kemp M, Kordofani AAY, Reed SG, El Hassan AM, Kharazmi A, Hag-Ali M, Mustafa MD, 1993. Prevalence of cutaneous leishmaniasis along the Nile River north of Khartoum (Sudan) in the aftermath of an epidemic in 1985. Am J Trop Med Hyg 48: 44-49.
17. Gaafar A, El Kadaro AY, Theander TG, Permin H, Ismail A, Kharazmi A, El Hassan AM, 1995. The pathology of cuta- neous leishmaniasis due to Leishmania major in Sudan Am J Trop Med Hyg 52: 438-442.
18. Kubba R, Al-Gindan Y, El Hassan AM, Omer AHS, 1987. Clinical diagnosis of cutaneous leishmaniasis (oriental sore). J Am Acad Dermatol 16: 1183-1189.
19. Gaafar A. Kharazmi A, Ismail A, Kemp M, Hey A, Christensen CBV, Dafalla M, El Kadaro AY, El Hassan AM, Theander TG, 1995. Dichotomy of the T cell response to Leishmania antigens in patients suffering from cutaneous leishmaniasis: absence or scanty of Th1 activity is associated with severe infections Clin Exp Immunol 100: 239-245.
20. Doyle PS, Engel JC, Pimenta PFP, Pinto da Silva P, Dwyer DM, 1991. Leishmania donovani: long-term culture of axenic amastigotes at 37°C. Exp Parasitol 73: 326-334.
21. Hey AS, Theander TG, Hviid L, Hazrati SM, Kemp M, Kharazmi A, 1994. The major surface glycoprotein (Gp63) from Leishmania major and Leishmania donovani cleaves CD4 molecules on human T cells. J Immunol 152: 4542-4548.
22. Facer CA, 1980. Direct antiglobulin reactions in Gambian children with P. falciparum malaria. III. Expression of IgG subclass determinants and genetic markers and association with anaemia. Clin Exp Immunol 41: 81-90.
23. Satti MH, 1987. Historical background of leishmaniasis in the Sudan. Sudan Med J (special issue): 1-2.
24. Nussenzweig V, Nussenzweig RS, 1986 Development of a sporozoite malaria vaccine. Am J Trop Med Hyg 35: 678-688.
25. Zavala F, Tam JP, Hollingdale MR, Cochrane AH, Quakyi I, Nussenzweig RS, Nussenzweig V, 1985. Rationale for development of a synthetic vaccine against Plasmodium falciparum malaria. Science 228: 1436-1438.
26. Shreffier WG, Burns JM, Badaro R. Ghalib HW, Button LL, McMaster WR, Reed SG, 1993. Antibody responses of visceral leishmaniasis patients to rgp63 a recombinant major surface glycoprotein of Leishmania species. J Infect Dis 167: 426-430.